Navigation Links
CPhI Annual Expert Industry Report (Part II): Live from CPhI Worldwide
Date:10/22/2013

FRANKFURT, Germany, October 22, 2013 /PRNewswire/ --

CPhI Expert Industry Panel Members Comment on Future Contingencies for Pharma in Part II of CPhI Industry Report

Pharma to change business model to include increased academic partnerships, CMO development work, more niched products, industry-wide QbD and regulation of suppliers

Report's expert highlights

Sam Venugopal, Director, Healthcare at PricewaterhouseCoopers:

  • Big pharma to develop niche medicines and associated companion diagnostics
  • Technical advances in design and development to reduce costs- with a more collaborative model between partners and increased outsourcing in development processes
  • Academic partnerships with pharma and CMOs to increase innovation

William Botha, Sensei, Interlean:

  • Increased outsourcing to lower risk processes such as packaging and logistics
    • Increased vertical integration when risks are higher (e.g. APIs)
  • Changing pharma business model towards niche products or commodity-based low margin products
  • Regulators to pay increased attention to human factors and staff turnover

Bikash Chatterjee, President and CTO, Pharmatech Associates:

  • Pharma to focus on improving drug discovery and development effectiveness
  • CMOs need to develop larger service development offerings
    • Understanding of foreign regulatory requirements, beyond FDA, to become increasingly common
  • FDAs enforcement of QbR in generics to reduce GMP transgressions

Ajaz Hussain, Inde
'/>"/>

SOURCE UBM Live
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Capsugel Previews New Generation, Easy-to-Open Sprinkle Capsule at CPhI Worldwide and AAPS Annual Meeting and Exposition
2. Medac Pharma, Inc. Announces Multiple Poster Presentations During the 2013 ACR/ARHP Annual Meeting
3. Additional Results of Global Primary Biliary Cirrhosis Study Group Analysis to be Presented at AASLD Annual Meeting
4. Pivotal Phase 3 Data from Boehringer Ingelheim Hepatitis C Portfolio to be Presented at 64th Annual AASLD Meeting
5. Mast Therapeutics To Present At The 12th Annual BIO Investor Forum On October 8
6. Simeprevir Data in Hepatitis C Patients to be Presented at the Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
7. Inovio Pharmaceuticals to Participate in Immunotherapy Panel and Present at the 12th Annual BIO Investor Forum
8. Astellas Employees to Change Tomorrow through Annual Day of Service
9. Olive Medical to Showcase 1080p HD All-In-One Visualization System for ENT Procedures at AAO-HNSF Annual Meeting
10. Patient Recruitment Expert CSS Tapped to Host Master Workshop and Roundtable Discussions at Annual SCRS Site Solutions Summit Conference in October
11. Data Presented at 49th EASD Annual Meeting Show Treatment with Lillys Investigational Dulaglutide Resulted in Improved Patient-Reported Health Outcomes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... STOCKHOLM , Dec. 22, 2014 Swedish ... Inc. today announced that the Committee for Medicinal Products ... (EMA) has adopted a positive opinion for the use ... adult men with Peyronie,s disease with a palpable plaque ... the start of therapy. The use of ...
(Date:12/22/2014)... , Dec, 22, 2014  Eiger BioPharmaceuticals ... 2a study of lonafarnib in patients with chronic ... conducted at the National Institutes of Health (NIH) ... .  The double-blinded, randomized, placebo-controlled, dose ascending study ... daily and 200 mg twice daily for 28 ...
(Date:12/22/2014)... TWi Biotechnology, Inc., today announced that ... TWi Biotechnology,s lead drug candidate, from The State ... for patent application numbered 201180018154.8.  This patent ... metabolite for treatment of type II diabetes.  The ... AC-201 for type II diabetes, and provides a ...
Breaking Medicine Technology:Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 2Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 3Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 4Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 5Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 6Eiger Bio Announces Positive Data in Patients Infected with Hepatitis Delta Virus (HDV) Treated with Lonafarnib - Results Presented at American Association for the Study of Liver Diseases (AASLD) Meeting 2Eiger Bio Announces Positive Data in Patients Infected with Hepatitis Delta Virus (HDV) Treated with Lonafarnib - Results Presented at American Association for the Study of Liver Diseases (AASLD) Meeting 3TWi Biotechnology Receives Notice of Patent Allowance for Its Lead Drug Candidate AC-201 for the Indication of Type II Diabetes in China 2TWi Biotechnology Receives Notice of Patent Allowance for Its Lead Drug Candidate AC-201 for the Indication of Type II Diabetes in China 3
... WIRE)--Jun 27, 2007 - Opexa,Therapeutics, Inc. (NASDAQ:OPXA), ... of cell therapies, presented,poster presentations at the ... Meeting (ISSCR) in Cairns, Queensland, Australia,from June ... of the International,Society for Cellular Therapy (ISCT) ...
... IIa Clinical Trial in Type 2,Diabetes Patients ... Transition,Therapeutics Inc. ("Transition") , today announces the ... indicating that 4-weeks of,daily treatments with gastrin-based ... control parameters, including,haemoglobinA1C (HbA1c), for 6 months ...
Cached Medicine Technology:Opexa Advances Monocyte Derived Islet Technology to Proof of,Principle in stz-induced NOD/SCID Mice 2Opexa Advances Monocyte Derived Islet Technology to Proof of,Principle in stz-induced NOD/SCID Mice 3A 4-Week Therapy with Transition Therapeutics' E1-I.N.T. Leads to,Sustained Reductions in Blood Glucose Levels for 6 Months,Post-treatment in Type 2 Diabetes Patients 2A 4-Week Therapy with Transition Therapeutics' E1-I.N.T. Leads to,Sustained Reductions in Blood Glucose Levels for 6 Months,Post-treatment in Type 2 Diabetes Patients 3A 4-Week Therapy with Transition Therapeutics' E1-I.N.T. Leads to,Sustained Reductions in Blood Glucose Levels for 6 Months,Post-treatment in Type 2 Diabetes Patients 4A 4-Week Therapy with Transition Therapeutics' E1-I.N.T. Leads to,Sustained Reductions in Blood Glucose Levels for 6 Months,Post-treatment in Type 2 Diabetes Patients 5
(Date:12/22/2014)... 22, 2014 As part of ... care service in San Diego and surrounding ... its senior care team with ongoing online training ... Care is provided by Caregiverlist®. Caregiverlist® is ... with the most reliable eldercare options, highest quality ...
(Date:12/22/2014)... December 22, 2014 Sagacious Consultants, the ... a subscription option to their ad hoc report writing ... services. Customers can sign up for an annual subscription ... each month at a deeply discounted hourly rate. ... each has a progressively discounted rate. Subscription hours are ...
(Date:12/22/2014)... NC (PRWEB) December 22, 2014 ... the current Ebola virus epidemic are receiving ... U.S. government agencies, nongovernmental organizations (NGOs) and ... remains ongoing, healthcare workers, emergency responders, patients ... technologies such as the CmTP MediDefense ...
(Date:12/22/2014)... The Bob Woodruff Foundation will ... more than $5 million in programs and organizations ... families. , This includes $1.3 million in grants ... with: veteran entrepreneurship; community impact; vocational training; transportation; ... injured veterans. , “The needs of those injured ...
(Date:12/22/2014)... Give a loved one the greatest gift of ... vitality. , For a limited time, HealthiPlus ( https://healthiplus.com/christmas-gift-packages/ ... special Holiday Wellness gift packages at drastically reduced prices ... contains cutting-edge, proven nutritional support for joints, mental functioning ... we age. , Joint Health Plus contains ...
Breaking Medicine News(10 mins):Health News:Golden Care Partners with Nationally Recognized Caregiver Training Service 2Health News:Sagacious Consultants’ New Subscription Packages Offer Customers Additional Report Writing Options 2Health News:Sagacious Consultants’ New Subscription Packages Offer Customers Additional Report Writing Options 3Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 2Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 3Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 4Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 5Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 2Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 3Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 4Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 5Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 6Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 7Health News:You Still Have Time to Give the Gift of Health and Vitality to a Mature Loved One 2
... Suicidal teens are not likely to get the ... team of researchers at Seattle Children,s Research Institute, the ... The study, "Adolescents With Suicidal Ideation: Health Care Use ... . The researchers found that only 13 ...
... (September 2011) Research conducted by Boston College neuroscientist Sean ... finds evidence of a new way of considering how the ... paper published in the latest issue of Nature Neuroscience ... magnetic resonance image (fMRI) to help them identify how the ...
... By Jenifer Goodwin HealthDay Reporter , TUESDAY, ... of lymph nodes after colon cancer surgery does not seem ... Researchers from the U.S. National Cancer Institute analyzed data ... and End Results (SEER) cancer registry. The investigators found ...
... Medicine have found that thyroid-stimulating hormone (TSH), a hormone ... function in the thyroid gland, can promote bone growth ... that TSH, or drugs that mimic its affect on ... osteoporosis and other conditions involving bone loss, such as ...
... (HealthDay News) --,Statins, a widely prescribed class of drugs used ... of brain bleeds in people who,ve had strokes, new research ... an ischemic stroke, caused by blocked blood flow to the ... two previous reviews raised concerns that statins might also raise ...
... previously unrelated imaging tools into one new device, a ... the University of Southern California has proposed a new ... through minimally invasive surgery. The new technique may be ... the ovaries. Ovarian cancer has a low ...
Cached Medicine News:Health News:Study finds over 70 percent of suicidal teens don't get the mental health services they need 2Health News:Study finds over 70 percent of suicidal teens don't get the mental health services they need 3Health News:Researchers utilize neuroimaging to show how brain uses objects to recognize scenes 2Health News:Screening Lots of Lymph Nodes Little Help for Colon Cancer Patients 2Health News:Screening Lots of Lymph Nodes Little Help for Colon Cancer Patients 3Health News:Pituitary hormone TSH found to directly influence bone growth 2Health News:Statins Don't Raise Risk of Brain Bleeds After Stroke: Study 2
... VenaCure Laser Vein Treatment. It is estimated ... worldwide have varicose veins. In the United States, ... of 60 suffer from painful and unsightly venous ... the capabilities of vascular therapy for the treatment ...
ELVeS is a new minimally-invasive laser treatment for patients with superficial vein reflux of the greater saphenous vein. The ELVeS laser treatment offers your patients an effective out-patient alt...
... technology provides practitioners with the ability to treat ... permanent hair reduction on all skin types and ... the practitioner to instantly switch to a 3, ... a simple twist of the handpiece dial while ...
... people are diagnosed with varicose veins every ... never seek treament and are apprehensive of ... them an effective alternative to conventional therapies., ... hook phlebectomy), is considered a laborious procedure ...
Medicine Products: